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Background: Polycystic Kidney Disease (PKD) is a genetic condition in which dedifferentiated and highly
proliferative epithelial cells form renal cysts and is frequently treated by renal transplantation. Studies have reported
that bone marrow-derived cells give rise to renal epithelial cells, particularly following renal injury as often occurs
during transplantation. This raises the possibility that bone marrow-derived cells from a PKD-afflicted recipient could
populate a transplanted kidney and express a disease phenotype. However, for reasons that are not clear the
reoccurrence of PKD has not been reported in a genetically normal renal graft. We used a mouse model to
examine whether PKD mutant bone marrow-derived cells are capable of expressing a disease phenotype in the
kidney.
Methods: Wild type female mice were transplanted with bone marrow from male mice homozygous for a PKD-
causing mutation and subjected to renal injury. Y chromosome positive, bone marrow-derived cells in the kidney
were assessed for epithelial markers.
Results: Mutant bone marrow-derived cells were present in the kidney. Some mutant cells were within the bounds
of the tubule or duct, but none demonstrated convincing evidence of an epithelial phenotype.
Conclusions: Bone marrow-derived cells appear incapable of giving rise to genuine epithelial cells and this is the
most likely reason cysts do not reoccur in kidneys transplanted into PKD patients.
Keywords: Bone marrow-derived epithelial cells, Cyst, Hematopoietic stem cells, Polycystic kidney disease,
Proliferation, Renal injuryBackground
Polycystic kidney disease (PKD) is a common genetic con-
dition (>1:1000 live births) involving the formation of
renal cysts [1]. The kidney is a system of tubules and ducts
formed by epithelial cells and it is these renal epithelial
cells from which cysts originate in PKD. Increased prolif-
eration of epithelial cells is a driver of cyst formation and
a distinctive feature of PKD that is exemplified by the
pathogenesis of the most common form of the disease,
autosomal dominant PKD (ADPKD) [2,3]. In ADPKD,
cysts have been reported to originate from the clonal* Correspondence: james.deane@monash.edu
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reproduction in any medium, provided the orexpansion of epithelial cells with an inherited mutation
plus an acquired somatic mutation of one of two ADPKD
genes (PKD1 or PKD2) [4-7]. Autosomal recessive PKD
(ARPKD) is a rarer childhood onset form of the disease
whose pathogenesis also involves high levels of epithelial
proliferation [8].
Renal transplantation is one of the few viable treatment
options for PKD patients. In light of continued, but somewhat
controversial, reports that cells derived from hematopoietic
stem cells in the bone marrow (BM) can integrate into the
kidney and form epithelial cells [9-16], this transplant situ-
ation raises some interesting questions. A phenotypically
normal donor kidney transplanted into a PKD afflicted re-
cipient may incorporate epithelial cells originating from
host BM cells carrying a PKD causing mutation. The
mobilization of bone marrow hematopoietic stem cells andal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reported to be enhanced by renal injury which is a com-
mon occurrence during the transplantation process
[9,11,12,17,18]. While there is a consensus that BM-
derived cells are not major contributors to epithelial repair
in the kidney, low level contributions have been reported
in several recent studies [13-16]. The proliferative pheno-
type of PKD epithelial cells could also be expected to amp-
lify the numbers of these cells after integration into the
kidney. Despite these possibilities, the reoccurrence of cysts
in a genetically normal donor kidney has not been reported
in PKD patients. While obvious macroscopic cystic mani-
festations of engrafted PKD cells can presumably be
excluded, the existence and phenotype of rare mutant epi-
thelial cells in the tubule has not been specifically investi-
gated. Previous studies of BM-derived renal epithelial cell
have used genetically normal BM and relied on tracing the
Y chromosome of male-derived BM cells in a kidney of fe-
male origin. The expression of epithelial markers by BM-
derived cells has been used to infer an epithelial phenotype,
although unambiguously determining whether a nuclear
Y-chromosome signal and a cytoplasmic epithelial marker
are in the same cell has proved difficult [19,20]. The ex-
pression of a cystic phenotype by BM-derived cells carrying
a PKD mutation, even at a microscopic level, would aid de-
tection and provide support for a genuine epithelial contri-
bution. A lack of cystic phenotype expression by mutant
BM-derived cell could either be interpreted as evidence
that the PKD phenotype of mutant cells is being sup-
pressed in the environment of the genetically normal kid-
ney, or be due to the lack of a BM-derived contribution to
renal epithelia. Distinguishing between these latter two
outcomes requires an understanding of the phenotype (epi-
thelial or otherwise) of BM-derived cells in the tubule.
While BM-derived cells with a PKD mutation appear to be
incapable of causing clinically relevant changes to the kid-
ney, their phenotype is potentially of interest with regard
to mechanisms of cystogenesis and sources of material for
cell-based reparative strategies. We investigated the pheno-
type of BM-derived PKD mutant cells in the kidney using a
controlled mouse model where tissue preparation and de-
tection techniques could be optimized. Our objective was
to investigate the nature of BM-derived cells in the kidney
by testing whether mutant bone marrow-derived cells can
express a cystic epithelial phenotype.
Methods
Experimental design
Wild type female mice underwent BM ablation and were
transplanted with mutant BM from male mice that were
homozygous for the PKD-causing Oak Ridge Polycystic
kidney disease gene [21,22]. Recipient mice then underwent
renal ischemia-reperfusion (IR) injury to induce trans-
planted BM cells to home to the kidney and give rise torenal epithelial cells. In this model, even a small contribu-
tion of BM-derived renal epithelial cells could potentially
result in cystogenesis due to the proliferative advantage
bestowed by the PKD-causing genetic defect. We assessed
whether transplanted BM cells gave rise to renal epithelium
and cysts using the male-specific Y chromosome to trace
mutant BM-derived cells in conjunction with markers of
renal epithelial phenotype.
Mouse PKD model
All experiments were conducted under the Australian
code of practice for the care and use of animals for scien-
tific purposes and were approved in advance by a Monash
University Animal Ethics Committee. Mice used were the
Oak Ridge Polycystic Kidney Disease strain (orpk) on a
C3H background, a recessive model of PKD. The genotype
of mice was determined by PCR amplification of frag-
ments of the mutant Tg737 or wild type gene from tail
DNA [23].
Sex mismatched bone marrow transplantation
Wild type female C3H mice (8–10 weeks) were irradiated
with a 10 Gray dose of gamma radiation delivered as two 5
Gray doses separated by three hours, to ablate BM. After ir-
radiation, recipient mice received 107 whole BM cells from
mutant male orpk donor mice with PKD (12–15 weeks) via
the tail vein. We have previously used this protocol with
GFP positive bone marrow and observed approximately
80% donor engraftment as measured in peripheral blood
[24]. BM engraftment was verified by amplifying the male-
specific Sry gene from the peripheral blood of recipients
using the primers 5’-CAGCTAACACTGATCTTTC-3’ and
5’-TTACTGGCCAGAAT-3’ [9]. Body weight was also
monitored as a measure of health.
Induction of renal ischemia-reperfusion injury
Six weeks after BM transplantation unilateral renal ische-
mia was induced under isoflurane anesthetic as previously
described [25]. Briefly, the left kidney was accessed by a
flank incision and the renal pedicel clamped for 45 min
using a specially designed vessel clip and forceps (S&T,
Fine Science Tools, Switzerland). The clip was removed
and reperfusion confirmed by a change in the color of the
kidney from purple to red. The incision was sutured and
anesthetic removed for recovery.
Histology and Y chromosome FISH
Mice were perfusion fixed with 4% paraformaldehyde
under anesthetic and kidneys collected 2 weeks (n = 2),
4 weeks (n = 3) or 12 weeks (n = 2) after the induction of
injury. Kidneys were embedded in paraffin and 6 μm sec-
tions cut. Sections were dewaxed in xylene, rehydrated
through graded alcohols to water and either stained with
Periodic Acid Schiffs for histology, or processed for Y
Figure 1 PCR for the Sry gene confirms the engraftment of
mutant bone marrow-derived cells in wild type mice. PCR-based
detection of the male-specific Sry gene in peripheral blood
confirmed the engraftment of male bone marrow cells in female
mice 4 weeks after transplantation. An 800 base pair band is present
in all genetically normal females transplanted with male mutant
bone marrow (Lanes1-6) and a male positive control (Lane 7), but is
absent from an untransplanted female negative control (Lane 8).
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Y chromosome FISH, sections were incubated in 1 M
sodium thiocyanate solution for 10 min at 80°C. They were
washed in PBS and digested in 0.4% w/v Pepsin in 0.1 M
HCl solution for 10 min at 37°C. The reaction was
quenched in 0.2% glycine in 2X PBS solution. The sections
were washed in PBS, post-fixed in 4% paraformaldehyde so-
lution for 2 min, washed in PBS, dehydrated through a
graded alcohol series and air dried. A TRITC labeled Y
chromosome paint (Star-FISH, Cambio, Cambridge, UK
Cat No 1200-YM Cy3-01) was added to each section, which
were then cover-slipped and sealed with rubber cement.
Slides were denatured at 65°C for 10 min and incubated
overnight at 37°C in a humidified chamber. Slides were
washed at 37°C in 3 changes of 50% formamide/ 2 X SSC
and 2 X SSC for 5 minutes and 4 X SSC/ 0.05% Tween-20
for 10 minutes. Slides were then washed in PBS, incubated
with either FITC labeled Lotus tetragonolobus agglutinin
(Vector Laboratories, UK, Cat No.FL-1321) in PBS (1:50)
for 2 hours at room temperature or underwent immuno-
fluorescence staining for pan cytokeratin using a primary
pan cytokeratin antibody (Dako Cytomation, Denmark)
and a secondary Alexa fluor 647 labeled anti-rabbit anti-
body (Invitrogen, Carlsbad, CA).
Quantification of Y chromosome-positive PKD mutant
cells in the kidney
Co-localization of the Y chromosome FISH signal and
DAPI staining in nuclei was used to identify BM-derived
PKD cells in recipient kidneys. A Provis Fluorescence
microscope (Olympus, Tokyo, Japan) was used to capture
randomly selected fields (40 × objective, 231 × 173 μm)
from the cortex and medulla of recipient kidneys 2 weeks,
4 weeks and 12 weeks post IR (2–3 mice per time point).
The percentage of Y chromosome positive cells was calcu-
lated based on at least 500 nuclei for each time point.
Analysis of co-staining for the Y chromosome and
epithelial markers
High power images (100 × objective 92 × 69 μm or 40 ×
objective 231 × 173 μm) of male control and female experi-
mental kidneys (2 weeks, 4 weeks and 12 weeks post IR)
stained with Y chromosome FISH, epithelial markers and
DAPI were captured on a Provis Fluorescence microscope
(Olympus, Tokyo, Japan). Composite images were created
using AnalySIS version 5.0 software (Olympus) to collate
separate channels where the TRITC Y-chromosome signal
was false colored green, the FITC conjugated LTA signal
was false colored red and DAPI colored blue. Images were
adjusted in a linear manner (brightness and contrast) if
required.
To allow three dimensional reconstruction of the renal
tubule, sequential confocal planes were imaged for each
field using an Olympus FluoView 1000 confocal microscope(Olympus, Centre Valley, Pennsylvania). To create com-
posite images TRITC Y-chromosome signals were false
colored green, FITC and Alexa 647 were false colored red
and DAPI colored blue. Images were adjusted in a linear
manner (brightness and contrast) and three dimensional
models of labeled cellular structures created using the
“surface” function of IMARIS (Bitplane, AG, Zurich,
Switzerland) at Monash MicroImaging. Images were com-
piled using Photoshop 5.5 (Adobe Systems, San Jose, CA).
Results
Confirmation of mutant PKD bone marrow engraftment
in recipients
Polymerase chain reaction (PCR)-based detection of the
male-specific Sry gene in peripheral blood confirmed the
engraftment of PKD mutant male BM in wild type female
mice 4 weeks after transplantation (Figure 1). This result
demonstrated that hematopoietic stem cells in the trans-
planted BM had repopulated the BM niche of recipients
and were producing circulating blood cells. Similar results
were observed 12 weeks after transplantation (data not
shown). Confirming the specificity of this assay, the Sry
gene was only detected in male positive control samples
and was not present in female negative control samples.
Mice also maintained body weight, another indicator of
successful engraftment (data not shown).
Wild type recipients of mutant bone marrow do not
exhibit the renal pathology of PKD
Compared to uninjured control kidneys (Figure 2A), kid-
neys of 12 wk old homozygous orpk mice used as BM
donors exhibited signs of PKD such as cysts, dilated tubules
and extracellular matrix expansion (Figure 2B). Twelve
weeks after renal IR, the kidneys of wild type recipients of
mutant BM (Figure 2C) were comparable to uninjured con-
trol kidneys (Figure 2A). This suggests extensive renal re-
pair and an absence of any major chronic pathology related
Figure 2 Wild type recipients of mutant bone marrow do not
exhibit PKD. (A and B) Compared to an age matched wild type
control (A), 12 wk old homozygous orpk mice (B) exhibited features
of PKD including cysts (#), dilated tubules (arrow) and increase in the
cellularity of the interstitium (*). (C) Wild type female mice
transplanted with mutant bone marrow demonstrated complete
renal repair 12 wks after injury and did not exhibit the
histopathology associated with PKD. Scale bar in C = 100 μm and A
& B are at the same magnification as C.
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velopment of PKD were observed in the kidneys of wild
type mice transplanted with mutant bone marrow and
subjected to renal IR (Figure 2C).
PKD mutant BM-derived cells are present in recipient
kidneys
Y chromosome FISH detected a signal in the nuclei of most
cells from male control kidney (Figure 3A). Detection rates
were not 100%, even in male control kidney, because the Y
chromosome is not always present in the remaining portion
of sectioned nuclei. The presence of the Y chromosome in
the kidneys of transplant recipients demonstrated that cells
derived from transplanted mutant male BM were present
in kidneys of genetically normal female transplant recipients
(Figure 3B). Quantification showed that BM-derived cells
carrying the Y chromosome in their nucleus were readily
observable 2, 4 and 12 weeks after IR (Figure 3C).
Co-staining for BM-derived cells and the proximal tubule
epithelial marker LTA
The phenotype of BM-derived cells was further character-
ized by co-staining with the proximal tubule (the injury-
susceptible initial segment of the renal tubule) epithelial
marker Lotus tetragonolobus agglutinin (LTA) and fluores-
cence microscopy (Figure 4). Following treatment of sec-
tions for Y chromosome FISH, LTA gave linear staining of
the outer extent of the proximal tubule and of the bush
border on the luminal side of the tubule. In control male
kidney, most LTA positive cells also contained a diffuse
Y-chromosome signal, while interstitial cells between LTA
positive epithelial cells contained a more compact Y
chromosome signal (Figure 4A & B). In wild type female
mice transplanted with mutant male BM, examples of BM-
derived cells that were clearly interstitial were detected and
displayed a compact Y chromosome signal as seen for
interstitial cells in male control tissue (Figure 4C). Rarer
examples of BM-derived cells were closely associated with
the renal tubule, but their Y chromosome signal was com-
pact as previously seen for interstitial cells (Figure 4D-H).
The phenotype and precise location of these cells, as
judged by LTA staining, was difficult to assess using con-
ventional fluorescence microscopy (Figure 4D-H). From
120 examples of Y chromosome positive cells examined,
Figure 3 Mutant Y chromosome positive cells derived from bone marrow are present in recipient kidneys. (A and B) Representative
fluorescence micrographs of Y chromosome-positive cells in the kidney are shown for a wild type male control (A) and a female recipient of
male mutant PKD BM 4 weeks post IR (B). Nuclei are counterstained with DAPI (blue). (C) Quantification of Y chromosome-positive cells per field
in transplanted females showed that BM-derived cells with the PKD mutation were detectable 2, 4 and 12 weeks post IR. Percentages of Y
chromosome positive cells are shown as mean ± SEM for at least 10 fields and a total of 500 nuclei per time point. Sections assessed were from
2 mice at 2 weeks, 3 mice at 4 weeks and 2 mice at 12 weeks.
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that an epithelial phenotype might be considered (2 cells at
2 weeks, 5 cells at 4 weeks and 3 cells at 12 weeks). These
frequencies and total numbers of Y chromosome-positive
cells observed are consistent with previous reports of BM-
derived cells in the tubule [13]. BM-derived cells were
found as scattered examples in the renal tubule and did
not appear as distinct clusters that might suggest a clonal
origin and a proliferative phenotype.
Three-dimensional reconstruction of BM-derived cells in
the recipient kidney
Confocal microscopy and three-dimensional reconstruction
allowed detailed examination of the colocalization of BM-derived cells with the proximal tubule marker LTA (Figure 5),
or the more general epithelial marker pan cytokeratin
(Figure 6). Male positive control mice clearly showed Y
chromosome positive epithelial cells which expressed LTA
(Figure 5A & B) or pan cytokeratin (Figures 6A & B). Y
chromosome positive cells that did not express epithelial
markers were also visible in the interstitial region between
tubules (Figures 5A & 6A). As previously seen by conven-
tional fluorescence microscopy, the Y chromosome signal of
interstitial cells was compact as opposed to the more diffuse
signal seen in epithelial cells. There were some examples of
Y chromosome positive BM-derived cells within the bounds
of the renal tubule, but these cells were not the same size or
morphology as renal tubular cells and contained a Y
Figure 4 (See legend on next page.)
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Figure 4 Y chromosome FISH detection of mutant BM-derived cells and the epithelial marker LTA in the kidney. (A-H) Conventional
fluorescence micrographs show bone marrow-derived, PKD mutant cells as detected by the presence of a Y chromosome (green). Sections are
costained with LTA as marker for the proximal tubule (red) and DAPI for nuclei (blue). (A and B) Male control kidney shows a Y chromosome
signal in most cells (A) which is diffuse in the tubules (B, white arrows) and more compact in interstitial cells (B, yellow arrows). (C) A low power
field from the kidney of a female transplanted with mutant male bone marrow showing several Y chromosome positive cells, some of which are
associated with the tubule (arrows). (D-H) Examples of Y chromosome positive cells that could be interpreted as proximal tubule epithelial cells,
but could equally be attributed to Y chromosome signals in the nuclei of infiltrating and overlaying non-epithelial cells as depicted by dashed
lines in inserts. Scale bar in A = 50μm; C is at the same magnification as A. Scale bar in B = 20 μm; D-H are at the same magnification as B. Insets
are at an additional 2X zoom.
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stitial cells (Figure 5C & D). There were also examples of Y
chromosome positive cells closely associated with the renal
epithelial layer. Careful examination of these cells did not
provide convincing evidence of the expression the renal epi-
thelial markers LTA (Figure 5C-F) or pan cytokeratin
(Figure 6C-F) and suggested that these cells were not epithe-
lial. Once again, the Y chromosome signal from these cells
was compact like that of interstitial cells. No convincing
examples of BM-derived renal epithelial cells were detected
despite the detailed examination of 14 candidate Y chromo-
some positive cells from the kidney 2 weeks, 4 weeks and
12 weeks after IR. The numbers of cells we considered (but
ultimately dismissed) as possible BM-derived epithelial cells
is comparable to the number of BM-derived epithelial cells
previously reported in a similar model not involving mutant
BM cells [13].Discussion
We investigated the fate of mutant BM-derived cells with
the potential to express a PKD phenotype in the genetically
normal kidney. Previous studies suggest that renal injury is
required to induce BM-derived cells to home to the kidney
and give rise to renal epithelium [10,12]. The duration of
renal ischemia and post ischemic recovery time have been
reported to affect BM engraftment [18]. In the current
study, recipient females underwent ischemia for 45 min, a
length of time that causes substantial but repairable damage
that has previously been reported to promote engraftment
[9,12]. A number of post-ischemic recovery times were
used to provide a wide window of opportunity to detect
BM-derived renal epithelium and any resulting cystogen-
esis. The shorter post ischemic time points studied (two
and four weeks) assessed whether a short proliferative
burst due to ischemic injury might facilitate transient en-
graftment [26]. The longer time point (twelve weeks)
assessed whether an extended post-ischemic recovery time
increased the window for engraftment and allowed more
time for cystic pathology to develop [18]. Thus our experi-
ments were designed to maximize the chances of observing
BM-derived renal epithelial cells in the recipient kidney.Despite successful BM-engraftment and recovery from
renal injury, histological examination did not detect any
polycystic changes in the kidneys of wild type recipients of
mutant bone marrow. In the absence of any gross path-
ology indicating cystogenesis, we used FISH to locate Y
chromosome positive, BM-derived cells in the kidney.
BM-derived cells were consistently found in the kidney 2,
4 and 12 weeks after injury. The BM-derived cells we
detected failed to exhibit the proliferative phenotype that
is characteristic of epithelial cells in PKD.
Since BM-derived cells failed to express a cystic features
that would indicate an epithelial phenotype, we were
limited to using the previously published combination of
Y-chromosome FISH combined with epithelial markers to
determine their nature. Conventional fluorescence mi-
croscopy of Y chromosome FISH combined with the epi-
thelial marker LTA detected BM-derived cells that could
be interpreted as being epithelial cells in the tubule. These
cells were found at a low frequency that is consistent with
previous reports of BM-derived epithelial cells [13]. How-
ever the compact Y chromosome signal in these BM-
derived cells was as seen for interstitial cells. To our
knowledge, this qualitative difference in the Y-
chromosome signal obtained from epithelial versus inter-
stitial cells on the kidney has not previously been used to
aid in determining the phenotype of BM-derived cells.
Confocal microscopy with three dimensional reconstruc-
tion also showed BM-derived cells within the boundary of,
or closely appressed to, renal tubules. However, closer
examination showed that in addition to having a compact
Y chromosome signal, these cells differed from host renal
epithelial cells with respect to their morphology and lack
of clear epithelial marker expression. This is in contrast to
epithelial cells in PKD which continue to express the epi-
thelial markers of the nephron segment from which they
originate [27]. Collectively these results suggest that, des-
pite our efforts to provide conditions favoring their forma-
tion and detection; in the situation we studied BM-derived
cells did not give rise to renal epithelial cells. We did not
further investigate the nature of BM-derived cells detected,
but based on previous studies they are likely to be macro-
phages, endothelial cells or myofibroblasts [24,28,29].
Figure 5 Mutant bone marrow-derived cells in the recipient kidney do not express the proximal tubule epithelial marker LTA. (A-F)
FISH, confocal microscopy and three dimensional modeling was used determine the nature of Y chromosome staining (green) relative to the
proximal tubule marker LTA (red) and DAPI stained nuclei (blue). Panels on the left (A, C and E) are confocal images with XZ and YZ planes
shown as side panels. The corresponding panels on the right (B, D and F) are 3D reconstructions of these confocal images. (A and B) A cross-
section of a tubule in a control male kidney showing dispersed Y chromosome signals in cells with typical epithelial morphology and LTA
staining (arrows). (C-F) Y chromosome positive mutant cells in wild type female recipient kidney. (C and D) An example of a Y chromosome-
positive cell (arrows) within the bounds of the proximal tubule that is not the same size or morphology as surrounding host tubular epithelial
cells and contains a more compact Y chromosome signal. (E and F) A cell with a compact Y chromosome signal closely bordering the proximal
tubule, but failing to express LTA. C and D are 4 wks after IR and E and F are 2 weeks after IR. Scale bars = 10 microns.
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humans and animal models, there are also studies suggest-
ing that these cells do not exist. Indeed, the apparent ab-
sence of BM-derived renal epithelial cells in our study is
consistent with previous reports where the fate of non-
PKD BM-derived cells has been traced in the kidney
[13,19]. While the rarity of BM-derived epithelial cells could
conceivably hamper detection, our experimental system isarguably more sensitive due to the potential of mutant BM-
derived cells to express a proliferative phenotype should
they give rise to epithelial cells. Many of the initial studies
in this area appear to have concluded that there is a BM-
derived contribution to renal epithelia due to unreliable tra-
cing and phenotype determination techniques [19]. We
have also noted a qualitative difference in the pattern of the
Y chromosome signal in tubular versus interstitial cells that
Figure 6 Mutant bone marrow-derived cells in the recipient kidney do not express the epithelial marker pan cytokeratin. (A-F) FISH,
confocal microscopy and three dimensional modeling was used determine the nature of Y chromosome staining (green) relative to the epithelial
marker pan cytokeratin (red) and DAPI stained nuclei (blue). Panels on the left (A, C and E) are confocal images with XZ and YZ planes shown as
side panels. The corresponding panels on the right (B, D and F) are 3D reconstructions of these confocal images. (A and B) A longitudinal-section
of a tubule in a control male kidney showing dispersed Y chromosome signals (arrows) in cells with typical epithelial morphology and pan
cytokeratin staining. (C-F) Y chromosome-positive mutant cells from the bone marrow (arrows) were found in close proximity to recipient pan
cytokeratin positive epithelial cells, but failed to stain for this marker themselves. C and D are 4 wks after IR and E and F are 12 weeks after IR.
Scale bars = 10 microns.
Verghese et al. BMC Nephrology 2012, 13:91 Page 9 of 11
http://www.biomedcentral.com/1471-2369/13/91aids determination of phenotype. The examples of BM-
derived cells in the kidney that we have presented here
could be misinterpreted as having an epithelial phenotype if
not carefully examined. Even if more definitive evidence of
BM-derived cells with epithelial characteristics was present,
the possibility remains that these cells are the product of fu-
sion between a BM-derived cell and a renal epithelial cell
[30]. While we did not detect cells fitting this description inour experiments, fusion with genetically normal epithelial
cells would be likely to rescue the proliferative phenotype
carried by mutant BM and reduce the probability of
detection.
Conclusions
The results from our mouse model add weight to sugges-
tions that cells derived from hematopoietic stem cells in the
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thelia. Extending this result to human renal transplantation,
we suggest that the most likely explanation for the failure of
PKD to reoccur in nonpolycystic renal grafts is due to the
absence of a genuine epithelial contribution to the trans-
planted kidney from the host bone marrow. The apparent in-
ability of hematopoietic stem cells to give rise to renal
epithelia is disappointing given the search for convenient
sources of stem cells for renal reparative therapies [31]. The
kidney’s major capacity for epithelial repair appears to rely
on the proliferation of intrinsic renal epithelial cells [19,32].
The most likely contribution of BM-derived cells, such as
macrophages and endothelial progenitors, is to provide
a supportive environment for endogenous epithelial re-
establishment [24,29,33].
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